Trial: 202103112

The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase

III (Cancer Control)

Principal Investigator

Adkins, Douglas

Disease Site

Lip, Oral Cavity and Pharynx

Learn more about this study at: clinicaltrials.gov